HR 1727
105th Congress
House
Health
Child health
Clinical trials
Commerce
Congress
Congressional reporting requirements
Drug approvals
Drug industry
Economic impact statements
Economics and Public Finance
Families
Government Operations and Politics
Government paperwork
Government publicity
Medical research
Pharmaceutical research
Science, Technology, Communications
Better Pharmaceuticals for Children Act
Introduced: May 22, 1997
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 18, 1997
Referred to the Subcommittee on Health and Environment.
May 22, 1997
Referred to the House Committee on Commerce.
May 22, 1997
Introduced in House
Plain-English summary
Better Pharmaceuticals for Children Act - Amends the Federal Food, Drug, and Cosmetic Act to allow for additional deferred effective dates for the approval of certain new drug applications to allow for additional pediatric information developed by further studies. Mandates development, publication, and annual updating of a list of approved drugs for which additional pediatric information may produce health benefits in the pediatric population.
What's happening now
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
2